Lv61
2255 积分 2020-05-07 加入
Bleeding and Coagulopathies in Critical Care
1小时前
求助中
Efficacy and Safety of the Bruton's Tyrosine Kinase Inhibitor Zanubrutinib in Immune Thrombocytopenia
16天前
已完结
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial
16天前
已完结
Patient survey in immune thrombocytopenia (ITP): Identifying unmet needs related to treatment and disease control in patients living in the United States
16天前
已完结
Does thrombophilia testing help in the clinical management of patients
27天前
已完结
How to manage venous thromboembolism risk during pregnancy in patients with inherited antithrombin deficiency?
1个月前
已完结
Lower-dose emicizumab prophylaxis: can less be more?
1个月前
已完结
Cardiovascular disease (CVD) in Canadians with haemophilia: Age‐Related CVD in Haemophilia Epidemiological Research (ARCHER study)
1个月前
已完结
Expert opinion paper on the treatment of hemophilia A with emicizumab
3个月前
已完结
Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study
4个月前
已完结
皖公网安备34019202002308
